Related Experiment Videos
Biogenesis and inactivation of catecholestrogens
J Weisz1, G A Clawson, C R Creveling
1Department of Obstetrics and Gynecology, M. S. Hershey Medical Center, Pennsylvania State University, Hershey 17033, USA.
Advances in Pharmacology (San Diego, Calif.)
|November 5, 1997
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Studies on catechol-O-methyltransferase in rat brain using two-dimensional gel electrophoresis.
Neurochemistry international·2010
Reduced COMT activity as a possible environmental risk factor for breast cancer. Opinion.
Neurotoxicity research·2004
A selection system for identifying accessible sites in target RNAs.
RNA (New York, N.Y.)·2001
T Cell subsets for therapy-unconventional CD1d-restricted natural killer T cells.
Advances in pharmacology (San Diego, Calif.)·2026
Tracking therapeutic T cells in vivo.
Advances in pharmacology (San Diego, Calif.)·2026
In vivo transduction of CAR T cells: Pharmacological principles, delivery platforms, and the road to clinical translation.
Advances in pharmacology (San Diego, Calif.)·2026
Transient T cell therapies.
Advances in pharmacology (San Diego, Calif.)·2026
Manufacturing as biology: How T-cell processing shapes therapeutic outcomes.
Advances in pharmacology (San Diego, Calif.)·2026
Engineering T cell metabolism to enhance therapeutic efficacy.
Advances in pharmacology (San Diego, Calif.)·2026
Arctigenin discovered by high-throughput screening ameliorates doxorubicin-induced cardiotoxicity as a novel natural KEAP1-NRF2 inhibitor.
Journal of pharmaceutical analysis·2026